semaglutide discovery The New York Times spotlighted

(2) studies with a duration of less than 24 weeks

The tricky part is that these symptoms can creep up so slowly, making it all too easy to adjust to a new, diminished "normal." But it's vital to distinguish between everyday burnout and the specific signs of this autoimmune condition if you want to take proactive steps to protect your future wellbeing

GLP-1 Pipeline Update: February 2026 Quarterly view of the GLP-1 pipeline and anticipated indications Editorial team Maryam Tabatabai, PharmD Editor-In-Chief Associate Vice President, Clinical Information Carole Kerzic, RPh Executive Editor Drug Information Pharmacist Principal Nicole Kjesbo, PharmD, BCPS Executive Editor Clinical Program Development Director Senior, Pipeline DISCLAIMER The drug pipeline is fluid

You can also compare how these outcomes stack up against earlier drugs using the retatrutide vs semaglutide comparison and the retatrutide vs Mounjaro breakdown